Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Medical Aesthetics Global Market Report 2025 Including: 1) By Product: Facial Aesthetic Products; Body Contouring Devices; Cosmetic Implants; Hair Removal Devices; Skin Aesthetic Devices; Tattoo Removal Devices; Thread Lift Products; Physician-dispensed Cosmeceuticals and Skin Lighteners; Physician-dispensed Eyelash Products; Nail Treatment Laser Devices 2) By Technology: Invasive; Non-Invasive; Minimally Invasive 3) By Distribution Channel: Direct Tender; Retail 4) By Application: Anti-Aging and Wrinkles; Facial and Skin Rejuvenation; Breast Enhancement; Body Shaping and Cellulite; Tattoo Removal; Vascular Lesions; Psoriasis and Vitiligo 5) By End User: Clinics, Hospitals, and Medical Spas; Beauty Centers; Home Care Covering: AbbVie Inc.; Medytox Inc.; Galderma S.A.; Alma Lasers Ltd.; Merz Pharma GmbH & Co. KGaA
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Biosimilars Market – Products, Applications and Regulations
... such as yeast, bacteria, or animal cells and are complex and sensitive to changes in manufacturing, in contrast to generic drugs, which are precise chemical replicas of small-molecule drugs. Biosimilars include various types of products, ... Read More
-
North America Hemodynamic Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... The COVID-19 pandemic significantly impacted the North American hemodynamic monitoring market. Patients with COVID-19 respiratory failure showed a marked rise in blood pressure over time, not accompanied by distinctive markers of circulatory failure. For instance, ... Read More
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Biopharmaceuticals – A Global Market Overview
... complex molecules, including proteins, nucleic acids, and vaccines, in contrast to traditional small-molecule drugs. Biopharmaceutical products are developed to address chronic, complex, and rare illnesses, providing targeted treatments that conventional drugs often lack. They are ... Read More
-
Global Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 ... Read More
-
Peptide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... investments and substantial funding for genomics and proteomics research are driving the demand for peptides in drug discovery and therapeutic development. Owing to the rising demand for effective protein-based drugs for the proper treatment process, ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
Enteral Feeding Tubes
... at a CAGR of 6.3% over the analysis period 2024-2030. Nasoenteric Enteral Feeding Tubes, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$2.9 Billion by the ... Read More
-
Cannabis Beverages
... CAGR of 16.3% over the analysis period 2024-2030. Non-Alcoholic Beverage, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More
-
Doxorubicin
... 5.8% over the analysis period 2024-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis period. ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the ... Read More
-
Animal Feed Additives
... at a CAGR of 5.4% over the analysis period 2024-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$20.7 Billion by the end of ... Read More
-
Medicated Skin Care Products
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Medicated Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$2.9 Billion by the ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Disabled and Elderly Assistive Technology
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Communication Aids, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$16.3 Billion ... Read More
-
Algae Omega 3 Ingredients
... 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. EPA / DHA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.0 Billion by ... Read More
-
Calcium Gluconate
... CAGR of 6.1% over the analysis period 2024-2030. Calcium Gluconate Powder, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$64.7 Million by the end of the ... Read More
-
Gas Masks
... CAGR of 7.0% over the analysis period 2024-2030. Disposable Respirators, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.8 Billion by the end of the analysis ... Read More
-
Novel Drug Delivery Systems (NDDS)
... Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by ... Read More
-
Pharmacy Repackaging Systems
... at a CAGR of 7.3% over the analysis period 2024-2030. Blister Card/Compliance Packaging Systems, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.0 Billion by the ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
Disposable Masks
... CAGR of 6.2% over the analysis period 2024-2030. Surgical Masks, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$19.1 Billion by the end of the analysis ... Read More
Research Assistance
